Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
about
A critical review of which children with acute myeloid leukaemia need stem cell procedures.Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML.Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children.A radioresistant fraction of acute promyelocytic leukemia cells exhibit CD38 cell-surface antigen and mRNA expression.
P2860
Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impact on long-term OS of cond ...... lle et de Thérapie Cellulaire.
@en
Impact on long-term OS of cond ...... lle et de Thérapie Cellulaire.
@nl
type
label
Impact on long-term OS of cond ...... lle et de Thérapie Cellulaire.
@en
Impact on long-term OS of cond ...... lle et de Thérapie Cellulaire.
@nl
prefLabel
Impact on long-term OS of cond ...... lle et de Thérapie Cellulaire.
@en
Impact on long-term OS of cond ...... lle et de Thérapie Cellulaire.
@nl
P2093
P2860
P50
P356
P1476
Impact on long-term OS of cond ...... elle et de Thérapie Cellulaire
@en
P2093
C Galambrun
E de Berranger
F Rialland
J-P Vannier
K Yakouben
P2860
P2888
P304
P356
10.1038/BMT.2013.185
P407
P577
2013-12-09T00:00:00Z
P5875
P6179
1036134746